» Articles » PMID: 29856118

Emotional Overactivity in Patients with Irritable Bowel Syndrome

Overview
Date 2018 Jun 2
PMID 29856118
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Negativity is often observed in patients with irritable bowel syndrome (IBS). No study has examined their emotional expressiveness as a marker of emotional reactivity. We investigated IBS patients' vulnerability to an emotional load by associating their expressiveness with psychological and neurophysiological assessments. We hypothesized that IBS would be characterized by a lack of expressiveness coupled with high scores in psychological and neurophysiological parameters.

Methods: We assessed the emotional facial expressions (EMFACS), psychological (anxiety, depression, alexithymia), and neurophysiological (cortisol, heart rate variability (HRV)) parameters of 25 IBS patients and 26 healthy controls (HC) while they watched fear-eliciting movie extracts.

Key Results: Overall, the task elicited an increase in state anxiety and consistent HRV responses. However, IBS patients differed from HC as they displayed more sadness and tended to display more rage. Contrary to HC, IBS patients showed an increase in heart rate and a decrease in parasympathetic regulation, reflecting an enhanced responsiveness corroborated by higher scores in depression and state anxiety. Consistent with their higher difficulty in identifying feelings, a component of alexithymia positively correlated with their expressions of rage, they were not aware of their increase in anxiety during the task, whereas HC were. No linear relationship between patients' expressions and their neurophysiological responses was found.

Conclusions & Inferences: Irritable bowel syndrome patients displayed greater emotional expressiveness with negative prevalence. This reflects an emotional vulnerability potentially related to low regulation skills and underscores the importance of considering the central dysregulation hypothesis in IBS as a promising avenue of research.

Citing Articles

Heart Rate Variability and Somatization in Adolescents With Irritable Bowel Syndrome.

Semen M, Lychkovska O, Kaminskyy D, Yavorskyi O, Semen K, Yelisyeyeva O J Neurogastroenterol Motil. 2023; 29(2):208-217.

PMID: 37019865 PMC: 10083117. DOI: 10.5056/jnm22019.


Improving Effect of Ellagic Acid on Sleep Quality and Gastrointestinal Symptoms in Patient With Irritable Bowel Syndrome: Randomized Double-Blind Clinical Trial.

Mirzaie Z, Bastani A, Hesami S, Pouryousefi E, Kavianpour M, Haghighian H Turk J Gastroenterol. 2021; 32(11):937-944.

PMID: 34872895 PMC: 8975483. DOI: 10.5152/tjg.2021.20344.


Randomized Cross Over Study Assessing the Efficacy of Non-invasive Stimulation of the Vagus Nerve in Patients With Axial Spondyloarthritis Resistant to Biotherapies: The ESNV-SPA Study Protocol.

Azabou E, Bao G, Costantino F, Jacota M, Lazizi C, Nkam L Front Hum Neurosci. 2021; 15:679775.

PMID: 34276328 PMC: 8278783. DOI: 10.3389/fnhum.2021.679775.


Different Dimensions of Affective Processing in Patients With Irritable Bowel Syndrome: A Multi-Center Cross-Sectional Study.

Berens S, Schaefert R, Ehrenthal J, Baumeister D, Eich W, Tesarz J Front Psychol. 2021; 12:625381.

PMID: 33854462 PMC: 8039143. DOI: 10.3389/fpsyg.2021.625381.


Alterations in Heart Rate Variability Associated With Irritable Bowel Syndrome or Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Sadowski A, Dunlap C, Lacombe A, Hanes D Clin Transl Gastroenterol. 2020; 12(1):e00275.

PMID: 33346998 PMC: 7752679. DOI: 10.14309/ctg.0000000000000275.